These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 24583458)
1. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction. Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458 [TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Cepinskas G; Katada K; Bihari A; Potter RF Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice]. Sun BW; Chen X; Chen ZY; Katada K; Cepinskas G Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3148-51. PubMed ID: 18269877 [TBL] [Abstract][Full Text] [Related]
4. [The inhibitory effects of extrinsic carbon monoxide-releasing molecules II on inflammatory responses in liver of mice with severe burns]. Sun BW; Chen X; Chen ZY; Kazuhiro K; Gediminas C Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):179-83. PubMed ID: 18019055 [TBL] [Abstract][Full Text] [Related]
5. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Mizuguchi S; Stephen J; Bihari R; Markovic N; Suehiro S; Capretta A; Potter RF; Cepinskas G Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H920-9. PubMed ID: 19561312 [TBL] [Abstract][Full Text] [Related]
6. Role of CO-releasing molecules liberated CO in attenuating leukocytes sequestration and inflammatory responses in the lung of thermally injured mice. Sun B; Sun H; Liu C; Shen J; Chen Z; Chen X J Surg Res; 2007 May; 139(1):128-35. PubMed ID: 17292406 [TBL] [Abstract][Full Text] [Related]
10. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model. Shen WC; Wang X; Qin WT; Qiu XF; Sun BW Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652 [TBL] [Abstract][Full Text] [Related]
11. Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC. Sun B; Zou X; Chen Y; Zhang P; Shi G Int J Biol Sci; 2008 Aug; 4(5):270-8. PubMed ID: 18726003 [TBL] [Abstract][Full Text] [Related]
12. Inhibitive Effects of Quercetin on Myeloperoxidase-Dependent Hypochlorous Acid Formation and Vascular Endothelial Injury. Lu N; Sui Y; Tian R; Peng YY J Agric Food Chem; 2018 May; 66(19):4933-4940. PubMed ID: 29708335 [TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner. Mizuguchi S; Capretta A; Suehiro S; Nishiyama N; Luke P; Potter RF; Fraser DD; Cepinskas G Free Radic Biol Med; 2010 Nov; 49(10):1534-41. PubMed ID: 20797432 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Bergstraesser C; Hoeger S; Song H; Ermantraut L; Hottenrot M; Czymai T; Schmidt M; Goebeler M; Ponelies N; Stich C; Loesel R; Molema G; Seelen M; van Son W; Yard BA; Rafat N Free Radic Biol Med; 2012 Feb; 52(4):794-802. PubMed ID: 22210380 [TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells. Maruyama K; Morishita E; Yuno T; Sekiya A; Asakura H; Ohtake S; Yachie A Thromb Res; 2012 Sep; 130(3):e188-93. PubMed ID: 22819264 [TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide-releasing molecule-3 (CORM-3) offers protection in an in vitro model of compartment syndrome. Bihari A; Chung KA; Cepinskas G; Sanders D; Schemitsch E; Lawendy AR Microcirculation; 2019 Oct; 26(7):e12577. PubMed ID: 31230399 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context. Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment of human cerebrovascular endothelial cells with CO-releasing molecule-3 interferes with JNK/AP-1 signaling and suppresses LPS-induced proadhesive phenotype. Serizawa F; Patterson E; Potter RF; Fraser DD; Cepinskas G Microcirculation; 2015 Jan; 22(1):28-36. PubMed ID: 25098198 [TBL] [Abstract][Full Text] [Related]